Amarin Corporation plc has appointed David Keenan, Ph.D., as Executive Vice President and Chief Operating Officer, effective October 17, 2025. Dr. Keenan previously served as Executive Vice President, Technical Operations and President of Europe, and has over 30 years of leadership experience in the biopharmaceutical and medical device industries.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amarin Corporation plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-246973), on October 22, 2025, and is solely responsible for the information contained therein.